D
David Eisenberg
Researcher at Technion – Israel Institute of Technology
Publications - 719
Citations - 120468
David Eisenberg is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Amyloid & Protein structure. The author has an hindex of 156, co-authored 697 publications receiving 112460 citations. Previous affiliations of David Eisenberg include Howard Hughes Medical Institute & Hebrew University of Jerusalem.
Papers
More filters
Journal ArticleDOI
The Persuasive Appeal of Alternative Medicine
Ted J. Kaptchuk,David Eisenberg +1 more
TL;DR: The possibility that the cultural beliefs and contextual practices of alternative medicine frame a pathway of words, behaviors, and experiences that people find persuasive, compelling, and, ultimately, restorative is examined.
Journal ArticleDOI
Molecular mechanisms for protein-encoded inheritance
Jed J.W. Wiltzius,Meytal Landau,Rebecca Nelson,Michael R. Sawaya,Marcin I. Apostol,Lukasz Goldschmidt,A.B. Soriaga,Duilio Cascio,Kanagalaghatta R. Rajashankar,David Eisenberg +9 more
TL;DR: New polymorphic crystal structures of segments ofPrion and other amyloid proteins are described, which offer two structural mechanisms for the encoding of prion strains that share features with the familiar mechanism for transfer of nucleic acid–encoded information into microbial strains, including sequence specificity and recognition by noncovalent bonds.
Journal ArticleDOI
Patterns and perceptions of care for treatment of back and neck pain: results of a national survey.
TL;DR: Chiropractic, massage, relaxation techniques, and other complementary methods all play an important role in the care of patients with back or neck pain.
Journal ArticleDOI
Half a century of amyloids: past, present and future
Pu Chun Ke,Pu Chun Ke,Ruhong Zhou,Ruhong Zhou,Louise C. Serpell,Roland Riek,Tuomas P. J. Knowles,Hilal A. Lashuel,Ehud Gazit,Ian W. Hamley,Thomas P. Davis,Thomas P. Davis,Marcus Fändrich,Daniel E. Otzen,Matthew George Chapman,Christopher M. Dobson,David Eisenberg,Raffaele Mezzenga +17 more
TL;DR: This review commemorates the conclusion of a half century since Eanes and Glenner's seminal study of amyloids in humans by documenting the major milestones in amyloid research to date, from the perspectives of structural biology, biophysics, medicine, microbiology, engineering and nanotechnology.
Journal ArticleDOI
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes.
Richard L. Fahrner,Thorsten Dieckmann,Sylvia S. L. Harwig,Robert I. Lehrer,David Eisenberg,Juli Feigon +5 more
TL;DR: The structure of PG-1 suggests ways in which the peptide may interact with itself or other molecules to form the membrane pores and the large membrane-associated assemblages observed in protegrin-treated, gram-negative bacteria.